PaulDavidSavageMDFACP
Oncology • Winston Salem, NCEndocrine Cancer, Melanoma, Sarcoma
Associate Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ
Dr. Savage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Section on Hematology and Oncology
Medical Center Boulevard
Winston Salem, NC 27157Phone+1 336-716-5847Fax+1 336-716-5687
Summary
- Dr. Paul Savage is an oncologist in Winston Salem, NC and is affiliated with multiple hospitals in the area, including Wake Forest Baptist Health-Lexington Medical Center and Wake Forest Baptist Medical Center. He received his medical degree from Tufts University School of Medicine and has been in practice 36 years. He specializes in endocrine cancer, melanoma, and sarcoma and is experienced in sarcomas, melanoma and cutaneous malignancies, general medical oncology, and endocrine oncology.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1984 - 1989
Rush University Medical CenterResidency, Internal Medicine, 1981 - 1984
Tufts University School of MedicineClass of 1981
Certifications & Licensure
NC State Medical License 1989 - 2025
MN State Medical License 1984 - 1989
IL State Medical License 1981 - 1984- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Gemcitabine in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 2000 Sep 01
- Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery Start of enrollment: 2013 Jul 31
- Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsPhase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.Paul D. Savage, James Lovato, K. Bridget Brosnihan, Antonius A. Miller, W. Jeffrey Petty
Sarcoma. 2016-11-08 - 32 citationsPoor prognosis of mediastinal germ cell cancers containing sarcomatous components.J. L. Gonzalez-Vela, Paul D. Savage, J. Carlos Manivel, Jane L. Torkelson, B. J. Kennedy
Cancer. 1990-09-15 - 55 citationsCystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.Robert E. Bechtold, Michael Y. M. Chen, C. A. Stanton, P. D. Savage, Edward A. Levine
Abdominal Imaging. 2003-11-01
Press Mentions
Abivax’s Phase I/II ABX196 in Second-Line HCC Draws Odds if Front-Line Shake-up Negatively Impacts Its Success TrajectoryFebruary 18th, 2021
From Calgary, Canada to Trivandrum, India Through Palliative CareJuly 11th, 2017
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
